Examination of the effects of arsenic on glucose homeostasis in cell culture and animal studies: Development of a mouse model for arsenic-induced diabetes

Toxicology and Applied Pharmacology

Volumn 222, Issue 3, 2007, Pages 305-314

  Paul, David S ^a   Hernández Zavala, Araceli ^b   Walton, Felecia S ^a   Adair, Blakely M ^c   Dědina, Jiří ^d   Matoušek, Tomáš ^d   Stýblo, Miroslav ^a,b  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^d INSTITUTE OF ANALYTICAL CHEMISTRY   (Czech Republic)

Author keywords

Arsenic; Arsenite; C57BL 6; Diabetes; Glucose tolerance; Speciation

Indexed keywords

ARSENIC TRIOXIDE; ARSENOSOBENZENE; CACODYLIC ACID; DRINKING WATER; GLUCOSE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARSENIC POISONING; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; LIVER; MALE; METABOLITE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS; SKELETAL MUSCLE;

ANIMALS; ARSENIC; BLOOD GLUCOSE; BODY WEIGHT; CELLS, CULTURED; DIABETES MELLITUS; DRINKING; GLUCOSE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; MALE; MICE; MICE, INBRED C57BL; TISSUE DISTRIBUTION;

ANIMALIA; MUS;

EID: 34547564794     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2007.01.010     Document Type: Article

References (92)

1. Alam M.G., Allinson G., Stagnitti F., Tanaka A., and Westbrooke M. Arsenic contamination in Bangladesh groundwater: a major environmental and social disaster. Int. J. Environ. Health Res. 12 (2002) 235-253
2. Bates M.N., Smith A.H., and Hopenhayn-Rich C. Arsenic ingestion and internal cancers: a review. Am. J. Epidemiol. 135 (1992) 462-476
3. Bates M.N., Smith A.H., and Cantor K.P. Case-control study of bladder cancer and arsenic in drinking water. Am. J. Epidemiol. 141 (1995) 523-530
4. Bazuine M., Ouwens D.M., Gomes de Mesquita D.S., and Maassen J.A. Arsenite stimulated glucose transport in 3T3-L1 adipocytes involves both Glut4 translocation and p38 MAPK activity. Eur. J. Biochem. 270 (2003) 3891-3903
5. Bazuine M., Carlotti F., Tafrechi R.S., Hoeben R.C., and Maassen J.A. Mitogen-activated protein kinase (MAPK) phosphatase-1 and -4 attenuate p38 MAPK during dexamethasone-induced insulin resistance in 3T3-L1 adipocytes. Mol. Endocrinol. 18 (2004) 1697-1707
6. Bencko V., Symon K., Chladek V., and Pihrt J. Health aspects of burning coal with a high arsenic content. II. Hearing changes in exposed children. Environ. Res. 13 (1977) 386-395
7. BGS and DPHE. Arsenic contamination of groundwater in Bangladesh. Vol. 1: summary. In: Kinniburgh D.G., and Smedley P.L. (Eds). British Geological Survey Report vol. WC/00/19 (2001) 1-22
8. Biswas U., Sarkar S., Bhowmik M.K., Samanta A.K., and Biswas S. Chronic toxicity of arsenic in goats: clinicobiochemical changes, pathomorphology and tissue residues. Small Rumin. Res. 38 (2000) 229-235
9. Boquist L., Boquist S., and Ericsson I. Structural beta-cell changes and transient hyperglycemia in mice treated with compounds inducing inhibited citric acid cycle enzyme activity. Diabetes 37 (1988) 89-98
10. Chang T.C., Hong M.C., and Chen C.J. Higher prevalence of goiter in endemic area of blackfoot disease of Taiwan. J. Formosan Med. Assoc. 90 (1991) 941-946
11. Chen C.J., Chuang Y.C., Lin T.M., and Wu H.Y. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res. 45 (1985) 5895-5899
12. Chen C.J., Chen C.W., Wu M.M., and Kuo T.L. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br. J. Cancer 66 (1992) 888-892
13. Chen C.J., Hsueh Y.M., Lai M.S., Shyu M.P., Chen S.Y., Wu M.M., Kuo T.L., and Tai T.Y. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 25 (1995) 53-60
14. Chen C.-J., Chiou H.-Y., Chiang M.-H., Lin L.-J., and Tai T.-Y. Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler., Thromb., Vasc. Biol. 16 (1996) 504-510
15. Chiang H.S., Hong C.L., Guo H.R., Lee E.F., and Chen T.Y. Comparative study on the high prevalence of bladder cancer in the blackfoot disease endemic area in Taiwan. Taiwan Yi Xue Hui Za Zhi 87 (1988) 1074-1080
16. Chiou H.Y., Hsueh Y.M., Liaw K.F., Horng S.F., Chiang M.H., Pu Y.S., Lin J.S., Huang C.H., and Chen C.J. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res. 55 (1995) 1296-1300
17. Chiou H.Y., Huang W.I., Su C.L., Chang S.F., Hsu Y.H., and Chen C.J. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke 28 (1997) 1717-1723
18. Chisolm Jr. J.J., and Thomas D.J. Developmental toxicity of metals-implications for public health. In: Clarkson T.W., Nordberg G.F., and Sager P.R. (Eds). Reproductive and Developmental Toxicity of Metals (1983), Plenum, New York 541-566
19. Cobo J.M., and Castineira M. Oxidative stress, mitochondrial respiration, and glycemic control: clues from chronic supplementation with Cr3+ or As3+ to male Wistar rats. Nutrition 13 (1997) 965-970
20. Devesa V., Del Razo L.M., Adair B., Drobna Z., Waters S.B., Hughes M.F., Styblo M., and Thomas D.J. Comprehensive analysis of arsenic metabolites by pH-specific hydride generation atomic absorption spectrometry. J. Anal. At. Spectrom. 19 (2004) 1460-1467
21. Díaz-Villaseñor A., Sanchez-Soto M.C., Cebrian M.E., Ostrosky-Wegman P., and Hiriart M. Sodium arsenite impairs insulin secretion and transcription in pancreatic beta-cells. Toxicol. Appl. Pharmacol. 214 (2006) 30-34
22. Dudek H., Datta S.R., Franke T.F., Birnbaum M.J., Yao R., Cooper G.M., Segal R.A., Kaplan D.R., and Greenberg M.E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275 (1997) 661-665
23. Elrick L.J., and Docherty K. Phosphorylation-dependent nucleocytoplasmic shuttling of pancreatic duodenal homeobox-1. Diabetes 50 (2001) 2244-2252
24. Engel R.R., Hopenhayn-Rich C., Receveur O., and Smith A.H. Vascular effects of chronic arsenic exposure: a review. Epidemiol. Rev. 16 (1994) 184-209
25. Fladeby C., and Serck-Hanssen G. Stress-induced glucose uptake in bovine chromaffin cells: a comparison of the effect of arsenite and anisomycin. Biochim. Biophys. Acta 1452 (1999) 313-321
26. Focazio, M.J., Welch, A.H., Watkins, S.A., Helsel, D.R., Horn, M.A., 1999. A retrospective analysis on the occurrence of arsenic on ground-water resources of the United States and limitations in drinking-water-supply characterizations: U.S. Geological Survey Water-Resources Investigation Report 99-4279. 21 pp.
27. Frost S.C., and Lane M.D. Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes. J. Biol. Chem. 260 (1985) 2646-2652
28. Frost S.C., Kohanski R.A., and Lane M.D. Effect of phenylarsine oxide on insulin-dependent protein phosphorylation and glucose transport in 3T3-L1 adipocytes. J. Biol. Chem. 262 (1987) 9872-9876
29. Ghafghazi T., Ridlington J.W., and Fowler B.A. The effects of acute and subacute sodium arsenite administration on carbohydrate metabolism. Toxicol. Appl. Pharmacol. 55 (1980) 126-130
30. Gould G.W., Lienhard G.E., Tanner L.I., and Gibbs E.M. Phenylarsine oxide stimulates hexose transport in 3T3-L1 adipocytes by a mechanism other than an increase in surface transporters. Arch. Biochem. Biophys. 268 (1989) 264-275
31. Guo H.R., Chiang H.S., Hu H., Lipsitz S.R., and Monson R.R. Arsenic in drinking water and incidence of urinary cancers. Epidemiology 8 (1997) 545-550
32. Haines H., McKenna T.M., and Melton J.E. Body fluid distribution in wild Mus musculus acclimated to water restriction. Am. J. Physiol. 235 (1978) R237-R242
33. Henriksen E.J., and Holloszy J.O. Effects of phenylarsine oxide on stimulation of glucose transport in rat skeletal muscle. Am. J. Physiol. 258 (1990) C648-C653
34. Hopenhayn-Rich C., Biggs M.L., Fuchs A., Bergoglio R., Tello E.E., Nicolli H., and Smith A.H. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology 7 (1996) 117-124
35. Hopenhayn-Rich C., Biggs M.L., and Smith A.H. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int. J. Epidemiol. 27 (1998) 561-569
36. Hughes M.F., and Thompson D.J. Subchronic dispositional and toxicological effects of arsenate administered in drinking water to mice. J. Toxicol. Environ. Health 49 (1996) 177-196
37. Hughes M.F., Devesa V., Adair B.M., Styblo M., Kenyon E.M., and Thomas D.J. Tissue dosimetry, metabolism and excretion of pentavalent and trivalent monomethylated arsenic in mice after oral administration. Toxicol. Appl. Pharmacol. 208 (2005) 186-197
38. IARC, 1987. Monograph on the Evaluation of Carcinogenic Risk to Humans-Overall Evaluation of Carcinogenicity: An Update of IARC Monographs 1 to 42.
39. Ibuki Y., and Goto R. Suppression of apoptosis by UVB irradiation: survival signaling via PI3-kinase/Akt pathway. Biochem. Biophys. Res. Commun. 279 (2000) 872-878
40. Izquierdo-Vega J.A., Soto C.A., Sanchez-Pena L.C., De Vizcaya-Ruiz A., and Del Razo L.M. Diabetogenic effects and pancreatic oxidative damage in rats subchronically exposed to arsenite. Toxicol. Lett. 160 (2006) 135-142
41. Jensen G.E., and Hansen M.L. Occupational arsenic exposure and glycosylated haemoglobin. Analyst 123 (1998) 77-80
42. Keller U., Szinnai G., Bilz S., and Berneis K. Effects of changes in hydration on protein, glucose and lipid metabolism in man: impact on health. Eur. J. Clin. Nutr. 57 Suppl. 2 (2003) S69-S74
43. Kohn A.D., Summers S.A., Birnbaum M.J., and Roth R.A. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J. Biol. Chem. 271 (1996) 31372-31378
44. Lai M.S., Hsueh Y.M., Chen C.J., Shyu M.P., Chen S.Y., Kuo T.L., Wu M.M., and Tai T.Y. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am. J. Epidemiol. 139 (1994) 484-492
45. Lewis D.R., Southwick J.W., Ouellet-Hellstrom R., Rench J., and Calderon R.L. Drinking water arsenic in Utah: a cohort mortality study. Environ. Health Perspect. 107 (1999) 359-365
46. Liebl B., Muckter H., Doklea E., Fichtl B., and Forth W. Influence of organic and inorganic arsenicals on glucose uptake in Madin-Darby canine kidney (MDCK) cells. Analyst 117 (1992) 681-684
47. Liebl B., Muckter H., Nguyen P.-T., Doklea E., Islambouli S., Fichtl B., and Forth W. Differential effects of various trivalent and pentavalent organic and inorganic arsenic species on glucose metabolism in isolated kidney cells. Appl. Orgamet. Chem. 9 (1995) 531-540
48. Macfarlane W.M., Smith S.B., James R.F., Clifton A.D., Doza Y.N., Cohen P., and Docherty K. The p38/reactivating kinase mitogen-activated protein kinase cascade mediates the activation of the transcription factor insulin upstream factor 1 and insulin gene transcription by high glucose in pancreatic beta-cells. J. Biol. Chem. 272 (1997) 20936-20944
49. Macfarlane W.M., McKinnon C.M., Felton-Edkins Z.A., Cragg H., James R.F., and Docherty K. Glucose stimulates translocation of the homeodomain transcription factor PDX1 from the cytoplasm to the nucleus in pancreatic beta-cells. J. Biol. Chem. 274 (1999) 1011-1016
50. Masahiko O., and Hideyasu A. Epidemiological studies on the Morinaga powdered milk poisoning incident. Jpn. J. Hyg. 27 (1973) 500-531
51. Matousek T., Dedina J., and Selecka A. Multiple microflame quartz tube atomizer-further development towards the ideal hydride atomizer for atomic absorption spectrometry. Spectrochim. Acta 57 (2002) 451-462
52. Mazumder D.N. Effect of chronic intake of arsenic-contaminated water on liver. Toxicol. Appl. Pharmacol. 206 (2005) 169-175
53. Mazumder D.N., Haque R., Ghosh N., De B.K., Santra A., Chakraborti D., and Smith A.H. Arsenic in drinking water and the prevalence of respiratory effects in West Bengal, India. Int. J. Epidemiol. 29 (2000) 1047-1052
54. McDowell H.E., Walker T., Hajduch E., Christie G., Batty I.H., Downes C.P., and Hundal H.S. Inositol phospholipid 3-kinase is activated by cellular stress but is not required for the stress-induced activation of glucose transport in L6 rat skeletal muscle cells. Eur. J. Biochem. 247 (1997) 306-313
55. Navas-Acien A., Silbergeld E.K., Streeter R.A., Clark J.M., Burke T.A., and Guallar E. Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence. Environ. Health Perspect. 114 (2006) 641-648
56. Ortsater H., Liss P., Akerman K.E., and Bergsten P. Contribution of glycolytic and mitochondrial pathways in glucose-induced changes in islet respiration and insulin secretion. Pfluegers Arch. 444 (2002) 506-512
57. Pal S., and Chatterjee A.K. Protective effect of N-acetylcysteine against arsenic-induced depletion in vivo of carbohydrate. Drug Chem. Toxicol. 27 (2004) 179-189
58. Pal S., and Chatterjee A.K. Protective effect of methionine supplementation on arsenic-induced alteration of glucose homeostasis. Food Chem. Toxicol. 42 (2004) 737-742
59. Pal S., and Chatterjee A.K. Prospective protective role of melatonin against arsenic-induced metabolic toxicity in Wistar rats. Toxicology 208 (2005) 25-33
60. Pasternak C.A., Aiyathurai J.E., Makinde V., Davies A., Baldwin S.A., Konieczko E.M., and Widnell C.C. Regulation of glucose uptake by stressed cells. J. Cell. Physiol. 149 (1991) 324-331
61. Paul, D.S., Harmon, A.W., Devesa, V., Thomas, D.J., Styblo, M., in press. Molecular mechanisms of the diabetogenic effects of arsenic: inhibition of insulin signaling by arsenite and methylarsonous acid. Toxicol. Appl. Pharmacol.
62. Petrick J.S., Jagadish B., Mash E.A., and Aposhian H.V. Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem. Res. Toxicol. 14 (2001) 651-656
63. Petro A.E., Cotter J., Cooper D.A., Peters J.C., Surwit S.J., and Surwit R.S. Fat, carbohydrate, and calories in the development of diabetes and obesity in the C57BL/6J mouse. Metabolism 53 (2004) 454-457
64. Rahman M., and Axelson O. Diabetes mellitus and arsenic exposure: a second look at case-control data from a Swedish copper smelter. Occup. Environ. Med. 52 (1995) 773-774
65. Rahman M., Wingren G., and Axelson O. Diabetes mellitus among Swedish art glass workers-an effect of arsenic exposure?. Scand. J. Work, Environ. Health 22 (1996) 146-149
66. Rahman M., Tondel M., Ahmad S.A., and Axelson O. Diabetes mellitus associated with arsenic exposure in Bangladesh. Am. J. Epidemiol. 148 (1998) 198-203
67. Rahman M., Tondel M., Chowdhury I.A., and Axelson O. Relations between exposure to arsenic, skin lesions, and glucosuria. Occup. Environ. Med. 56 (1999) 277-281
68. Santra A., Das Gupta J., De B.K., Roy B., and Guha Mazumder D.N. Hepatic manifestations in chronic arsenic toxicity. Indian J. Gastroenterol. 18 (1999) 152-155
69. Schliess F., and Haussinger D. Cell hydration and insulin signalling. Cell. Physiol. Biochem. 10 (2000) 403-408
70. Schliess F., and Haussinger D. Call volume and insulin signaling. Int. Rev. Cytol. 225 (2003) 187-228
71. Smith A.H., Hopenhayn-Rich C., Bates M.N., Goeden H.M., Hertz-Picciotto I., Duggan H.M., Wood R., Kosnett M.J., and Smith M.T. Cancer risks from arsenic in drinking water. Environ. Health Perspect. 97 (1992) 259-267
72. Smith A.H., Goycolea M., Haque R., and Biggs M.L. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am. J. Epidemiol. 147 (1998) 660-669
73. Somwar R., Koterski S., Sweeney G., Sciotti R., Djuric S., Berg C., Trevillyan J., Scherer P.E., Rondinone C.M., and Klip A. A dominant-negative p38 MAPK mutant and novel selective inhibitors of p38 MAPK reduce insulin-stimulated glucose uptake in 3T3-L1 adipocytes without affecting GLUT4 translocation. J. Biol. Chem. 277 (2002) 50386-50395
74. Souza K., Maddock D.A., Zhang Q., Chen J., Chiu C., Mehta S., and Wan Y. Arsenite activation of P13K/AKT cell survival pathway is mediated by p38 in cultured human keratinocytes. Mol. Med. 7 (2001) 767-772
75. Sowell M.O., Robinson K.A., and Buse M.G. Phenylarsine oxide and denervation effects on hormone-stimulated glucose transport. Am. J. Physiol. 255 (1988) E159-E165
76. Surwit R.S., Kuhn C.M., Cochrane C., McCubbin J.A., and Feinglos M.N. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37 (1988) 1163-1167
77. Surwit R.S., Feinglos M.N., Rodin J., Sutherland A., Petro A.E., Opara E.C., Kuhn C.M., and Rebuffe-Scrive M. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 44 (1995) 645-651
78. Sviderskaya E.V., Jazrawi E., Baldwin S.A., Widnell C.C., and Pasternak C.A. Cellular stress causes accumulation of the glucose transporter at the surface of cells independently of their insulin sensitivity. J. Membr. Biol. 149 (1996) 133-140
79. Sweeney G., Somwar R., Ramlal T., Volchuk A., Ueyama A., and Klip A. An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. J. Biol. Chem. 274 (1999) 10071-10078
80. Tanti J.F., Grillo S., Gremeaux T., Coffer P.J., Van Obberghen E., and Le Marchand-Brustel Y. Potential role of protein kinase B in glucose transporter 4 translocation in adipocytes. Endocrinology 138 (1997) 2005-2010
81. Thomas D.J., and Goyer R.A. Effects of arsenic, lead and cadmium on the cardiovascular system. Metal Toxicology (1995), Academic Press, New York 265-285
82. Tseng W.P., Chu H.M., How S.W., Fong J.M., Lin C.S., and Yeh S. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 40 (1968) 453-463
83. Tseng C.H., Chong C.K., Chen C.J., Lin B.J., and Tai T.Y. Abnormal peripheral microcirculation in seemingly normal subjects living in blackfoot-disease-hyperendemic villages in Taiwan. Int. J. Microcirc.: Clin Exp. 15 (1995) 21-27
84. Tseng C.H., Chong C.K., Chen C.J., and Tai T.Y. Lipid profile and peripheral vascular disease in arseniasis-hyperendemic villages in Taiwan. Angiology 48 (1997) 321-335
85. Tseng C.H., Tai T.Y., Chong C.K., Tseng C.P., Lai M.S., Lin B.J., Chiou H.Y., Hsueh Y.M., Hsu K.H., and Chen C.J. Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan. Environ. Health Perspect. 108 (2000) 847-851
86. Tsuda T., Babazono A., Yamamoto E., Kurumatani N., Mino Y., Ogawa T., Kishi Y., and Aoyama H. Ingested arsenic and internal cancer: a historical cohort study followed for 33 years. Am. J. Epidemiol. 141 (1995) 198-209
87. Walton F.S., Harmon A.W., Paul D.S., Drobna Z., Patel Y.M., and Styblo M. Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes. Toxicol. Appl. Pharmacol. 198 (2004) 424-433
88. Warren A.P., James M.H., Menzies D.E., Widnell C.C., Whitaker-Dowling P.A., and Pasternak C.A. Stress induces an increased hexose uptake in cultured cells. J. Cell. Physiol. 128 (1986) 383-388
89. WHO Factsheet, 2001. Arsenic in drinking water. Accessed: October 1, 2006. http://www.who.int/mediacentre/factsheets/fs210/en/index.html.
90. Widnell C.C., Baldwin S.A., Davies A., Martin S., and Pasternak C.A. Cellular stress induces a redistribution of the glucose transporter. FASEB J. 4 (1990) 1634-1637
91. Wu M.M., Kuo T.L., Hwang Y.H., and Chen C.J. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am. J. Epidemiol. 130 (1989) 1123-1132
92. Zhou H., Li X.-M., Meinkoth J., and Pittman R.N. Akt regulates cell survival and apoptosis at a postmitochondrial level. J. Cell Biol. 151 (2000) 483-494 10.1083/jcb.151.3.483